Sign in
4

Changes in Ownership

C4 Therapeutics, Inc. Filed Acc 0001470831-26-000179

Chief Scientific Officer gave up 2,446 shares (to pay taxes)

  • Chief Scientific Officer acquired 240,000 shares (grant or award)
  • Chief Scientific Officer acquired 7,050 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Mahaney Paige Chief Scientific Officer 2026-02-13 Grant or award +240,000 339,356 D: show line 1 in the form
Mahaney Paige Chief Scientific Officer 2026-02-14 Option exercise +7,050 339,356 D: show line 2 in the form
Mahaney Paige Chief Scientific Officer 2026-02-14 Shares withheld for taxes −2,446 $1.89 $4,623 336,910 D: show line 3 in the form
Loading xslF345X05/wk-form4_1771452309.xml…